Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal

Blood. 1995 Sep 15;86(6):2063-72.
No abstract available

Publication types

  • Review

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / prevention & control
  • Bone Marrow Transplantation / adverse effects
  • Candidiasis / prevention & control
  • Clinical Trials as Topic
  • Disease Susceptibility
  • Drug Administration Routes
  • Hematopoietic Cell Growth Factors / therapeutic use
  • Humans
  • Immunocompromised Host
  • Leukocyte Transfusion
  • Mycoses / drug therapy
  • Mycoses / prevention & control*
  • Neoplasms / complications*
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Neutropenia / complications
  • Triazoles / administration & dosage
  • Triazoles / adverse effects
  • Triazoles / therapeutic use

Substances

  • Antifungal Agents
  • Hematopoietic Cell Growth Factors
  • Triazoles
  • Amphotericin B